William Hildebrand to Neoplasms
This is a "connection" page, showing publications William Hildebrand has written about Neoplasms.
Connection Strength
0.905
-
NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors. Cancer Immunol Res. 2018 06; 6(6):636-644.
Score: 0.310
-
Expanding the targets available to therapeutic antibodies via novel disease-specific markers. Int Rev Immunol. 2011 Oct-Dec; 30(5-6):312-27.
Score: 0.198
-
Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Expert Rev Proteomics. 2006 Dec; 3(6):641-52.
Score: 0.141
-
Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing. Clin Transl Med. 2022 07; 12(7):e937.
Score: 0.104
-
MHC-I Genotype Restricts the Oncogenic Mutational Landscape. Cell. 2017 Nov 30; 171(6):1272-1283.e15.
Score: 0.075
-
Amyloid precursor-like protein 2 association with HLA class I molecules. Cancer Immunol Immunother. 2009 Sep; 58(9):1419-31.
Score: 0.041
-
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol. 2006 Oct 15; 177(8):5088-97.
Score: 0.035